Opaleye Management Inc.

Position in FDMT — 4D Molecular Therapeutics, Inc.

CIK 1595855 Boston, MA

Position in FDMT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,448,012

+$3,402,583 QoQ

Shares Held

334,437

+197.8% QoQ

Ownership

0.463%

of shares outstanding

% of Portfolio

0.41%

of 13F equity value

Holder Rank

#32

of 158 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Opaleye Management Inc. holds $678,840,611 across 50 Biotechnology names. FDMT ranks #33 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IRON	Disc Medicine, Inc.	855,000	$62,534,700
2	URGN	UroGen Pharma Ltd.	1,439,996	$52,991,852
3	APGE	Apogee Therapeutics, Inc.	390,000	$51,764,700
4	MGTX	MeiraGTx Holdings plc	3,550,000	$47,960,500
5	SLGL	Sol-Gel Technologies Ltd.	500,000	$37,070,000
6	RZLT	Rezolute, Inc.	6,300,000	$32,760,000
7	TGTX	Tg Therapeutics, Inc.	535,000	$29,392,900
8	IMMX	Immix Biopharma, Inc.	2,345,000	$24,176,950

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,448,012	334,437	+197.8%	Shares	Sole	2026-08-14
2026-03-31	$1,045,429	112,291	-67.5%	Shares	Sole	2026-05-15
2024-06-30	$7,257,292	345,750	+0.5%	Shares	Sole	2024-08-14
2024-03-31	$10,963,758	344,123	+11.5%	Shares	Sole	2024-05-29
2023-12-31	$6,250,210	308,500	0.0%	Shares	Sole	2024-02-14
2023-09-30	$3,927,205	308,500	+39.2%	Shares	Sole	2023-11-15
2023-06-30	$4,006,119	221,700	-29.4%	Shares	Sole	2023-08-14
2023-03-31	$5,397,660	314,000	-4.8%	Shares	Sole	2023-05-15
2022-12-31	$7,329,300	330,000	-5.9%	Shares	Sole	2023-02-10
2022-09-30	$2,819,628	350,700	+7.9%	Shares	Sole	2022-11-14
2022-06-30	$2,268,500	325,000	0.0%	Shares	Sole	2022-08-15
2022-03-31	$4,914,000	325,000	+41.9%	Shares	Sole	2022-05-16
2021-12-31	$5,024,260	229,000	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.